Dr. Edith Lord is a Professor of Microbiology & Immunology and Oncology. Dr. Lord received her BA degree in microbiology from the University of Kansas in 1970 and a Ph.D degree in immunology from the University of California at San Diego in 1975. She was a postdoctoral fellow at the University of ...
Dr. Edith Lord is a Professor of Microbiology & Immunology and Oncology. Dr. Lord received her BA degree in microbiology from the University of Kansas in 1970 and a Ph.D degree in immunology from the University of California at San Diego in 1975. She was a postdoctoral fellow at the University of California at San Francisco. As a faculty member since 1976, Dr. Lord has demonstrated excellence as a scientist and dedication to the training of graduate students and postdoctoral fellows.
From 2006-2008, Dr. Lord led the graduate program in the Department of Microbiology and Immunology. She was the Senior Associate Dean for Graduate Education and Postdoctoral Affairs at the School of Medicine and Dentistry from 2008-2018.
In her research, Dr. Lord focuses on the immune responses that can control tumor development and how immune cells function within the unique microenvironment of growing tumors. She has published, as author and co-author, more than 130 scientific articles and continues her passion for research today.
Faculty Appointments
Professor Emerita
-
Department of Microbiology and Immunology (SMD)
Credentials
Education
PhD | Univ of Cal San Diego.Immunology.1975
BA | University of Kansas.Microbiology.1970
Awards
Graduate Student Society Advocacy Award.2018
Research
Patents
Detection of Hypoxia with Reagents Containing 2-Nitroimidazole Compounds and Methods of Making such Reagents.
Issue date: July 30, 1996
Patent #: 5,540,908
Country: United States
Inventors: Cameron J Koch, Edith M Lord
Detection of Hypoxia
Issue date: December 01, 1998
Patent #: 5,843,404
Country: United States
Inventors: Cameron J Koch, Edith M Lord
Method of Monitoring Exposure to Bowman Birk Inhibitor Using Monoclonal Antibodies Against Bowman Birk Inhibitor Metabolites
Issue date: April 08, 1997
Patent #: 5,618,679
Country: United States
Inventors: Ann R Kennedy, Cameron J Koch, Edith M Lord, Xingsheng Wan
Monoclonal Antibodies Differentially Reactive with Native and Reductively Modified Bowman-Birk Protease Inhibitor
Issue date: April 01, 1997
Patent #: 5,616,492
Country: United States
Inventors: Ann R Kennedy, Cameron J Koch, Edith M Lord, Xingsheng Wan
Mills BN, Connolly KA, Ye J, Murphy JD, Uccello TP, Han BJ, Zhao T, Drage MG, Murthy A, Qiu H, Patel A, Figueroa NM, Johnston CJ, Prieto PA, Egilmez NK, Belt BA, Lord EM, Linehan DC, Gerber SA
Cell reports.. 2019 October 829 (2):406-421.e5. Epub 1900 01 01.
McAdam AJ, Felcher A, Woods ML, Pulaski BA, Hutter EK, Frelinger JG, Lord EM
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.. 1994 April 15 (3):155-64. Epub 1900 01 01.
McAdam AJ, Yeh KY, Pulaski BA, Frelinger JG, Lord EM
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.. 1993 November 14 (4):293-7. Epub 1900 01 01.
